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Abstract
Objective: The main aim of this study was to assess the association between adherence to the traditional
Mediterranean diet (MedDiet) and health-related quality of life (HRQoL) and treatment satisfaction in patients with
type 2 diabetes mellitus (T2DM).
Methods: This cross-sectional study included 294 patients with T2DM (146 with diabetic retinopathy and 148
without retinopathy). HRQoL and treatment satisfaction were assessed with the Audit Diabetes-Dependent Quality
of Life and Diabetes Treatment Satisfaction Questionnaires, respectively. Adherence to the MedDiet was evaluated
with the relative Mediterranean Diet Score (rMED). The rMED was added to multivariate linear regression models to
assess its relative contribution as a quantitative as well as a qualitative variable after recoding to maximize each of
the model’s coefficients of determination to explain quality of life as well as treatment satisfaction dimensions.
Results: The adherence to the Mediterranean diet showed no significant association with the overall quality of life
score. However, rMED was associated with some HRQoL dimensions: travels, self-confidence and freedom to eat
and drink (p = 0.020, p = 0.015, p = 0.037 and p = 0.015, respectively). Concerning treatment satisfaction, rMED was
positively associated with its overall score (p = 0.046), and especially with the understanding of diabetes (p = 0.0004)
and treatment recommendation (p = 0.036), as well as with the perceived frequency of hyperglycaemias (p = 0.039).
Conclusion: Adherence to the Mediterranean diet was associated with greater treatment satisfaction in patients
with T2DM. Although we found no association with overall HRQoL, adherence to this dietary pattern was
associated with some quality of life dimensions.
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Mediterranean diet
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Background
Despite the fact that there is increasing scientific evi-
dence on the role of the traditional Mediterranean Diet
(MedDiet) as an indicator of physical and mental health
and of healthy ageing in several population subgroups
(adolescents, university students, general population,
elderly people, and subjects with high blood pressure),
there are very few data available on the relationship of
the food intake pattern with quality of life and treatment
satisfaction in patients with type 2 diabetes mellitus
(T2DM) [1–6]. Kahleova et al. assessed the impact of
two low calorie diet interventions (vegetarian diet vs.
conventional diabetes diet), to which a programme of
aerobic exercise was added, on health-related quality of
life (HRQoL), eating behaviour and mood of obese pa-
tients with T2DM [7]. The results showed the positive
effect of a low calorie vegetarian food regime on the
quality of life and mood of these patients [7]. A recent
sub-analysis of the PREDIMED trial demonstrated the
role attributable to the Mediterranean diet regime,
enriched with nuts, in the prevention of unipolar depres-
sion in patients with T2DM [8].
In T2DM, maintaining quality of life and treatment
satisfaction are important treatment goals for the patient
and are increasingly important in health decision-
making [9, 10]. Both outcome variables demonstrated
their association with lower morbidity and mortality,
greater treatment adherence and positive changes in
lifestyle-related aspects [10, 11].
Medical nutrition therapy, as an integral part of
diabetes education, is a cornerstone in the comprehen-
sive approach to diabetes [12]. The implementation of
interventions which facilitate a change of lifestyle is
fundamental to achieve the therapeutic goals and delay
its advanced complications [13]. The MedDiet is a refer-
ence as a healthy eating pattern and is also a suitable
dietary approach for the management of diabetes and its
associated cardiovascular risk factors [14].
In view of all the above, we hypothesized that greater
adherence to the MedDiet by patients with T2DM is
associated with greater quality of life and treatment
satisfaction. The aim of this study was to explore the as-
sociation between adherence to the MedDiet and quality
of life and treatment satisfaction in patients with T2DM.
Additionally, we also analyzed the relationship between
each component of the Audit of Diabetes Dependent
Quality of Life (ADDQoL-19) and Diabetes Treatment
Satisfaction Questionnaire (DTSQ) with adherence to
the traditional Mediterranean diet (rMED).
Methods
Study design and population
We used the data obtained in a cross-sectional study de-
signed with the aim of assessing the differences in terms
of HRQoL and treatment satisfaction in patients with
T2DM with retinopathy. Five out of the 299 participants
in the initial study declined to participate in the nutri-
tional assessment. Therefore, this post-hoc analysis in-
cluded 294 participants from the previous study. The
results of that study have already been communicated in
a previous publication [15]. A detailed description of the
study design and methodology, and of the patient char-
acteristics has therefore already been provided. In the
previously published study on HRQoL and treatment
satisfaction, we were able to demonstrate that the pres-
ence and severity of retinopathy, duration of diabetes
and treatment with insulin were associated with worse
scores in HRQoL. Treatment satisfaction was affected by
diabetes duration, treatment with insulin and the sever-
ity of macular oedema [15]. None of the patients in-
cluded had prior cardiovascular complications or other
advanced complications of diabetes. All participants
signed an informed consent form. The study was ap-
proved by the local Ethics Committee.
Health-related quality of life
To assess HRQoL, we used the Spanish version of the
specific quality of life questionnaire for diabetic patients,
the Audit of Diabetes-Dependent Quality of Life
(ADDQoL-19), specifically designed to measure the indi-
vidual perspective of the impact of diabetes and its treat-
ment on quality of life [16]. The first two items are of a
general in nature and are scored separately. The first
one assesses current quality of life, with scores going
from −3 (extremely bad) to +3 (excellent), and the sec-
ond one analyzes the overall impact of diabetes on qual-
ity of life, with scores going from −3 (maximum negative
impact of diabetes) to +1 (maximum positive impact of
diabetes). The individual items include questions about
19 specific areas of life. This questionnaire allows a
weighted final score of the effects of diabetes and its
treatment on patient quality of life, which ranges from
−9 (maximum negative impact of diabetes) to +3 (max-
imum positive impact of diabetes) [17].
Treatment satisfaction
To measure the satisfaction with treatment we used the
specific Diabetes Treatment Satisfaction Questionnaire
(DTSQ), designed with the aim of assessing the degree
of treatment satisfaction in the adult patients with type 1
and type 2 diabetes [18]. Its use has been recommended
by the World Health Organization and the International
Diabetes Federation, and it has been validated in the
Spanish population [19, 20]. The DTSQ-s questionnaire
consists of 8 items which allow 7 possible answers,
which range from 0 (very dissatisfied) to 6 (extremely
satisfied) points each. On adding 6 of the 8 items we ob-
tain an overall satisfaction score which ranges from 0
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points (least satisfaction possible expressed by means of
the questionnaire) to 36 points (greatest satisfaction
possible expressed by means of the questionnaire). The
two remaining items, which refer to the frequency of ep-
isodes of hyperglycaemias and hypoglycaemias perceived
by the patient, can range from 0 (never) to 6 (most of
the time), and are analyzed in an individual and descrip-
tive manner. Higher scores are indicative of higher levels
of current treatment satisfaction [18]. All the question-
naires were administered by trained personnel.
Dietary data
Daily food and nutrient intake was assessed using a
semi-quantitative food frequency questionnaire of 101
items, validated for the Spanish population (available at:
http://bibliodieta.umh.es/cfa-101-inma) [21]. Its use
allowed us to obtain the daily nutrient intake and the
food quality index, the relative Mediterranean Diet score
(rMED) [22]. The rMED food quality index allowed us
to assess the level of adherence to the MedDiet on a
linear scale of 18 points. All the components, except for
alcohol, were assessed in grams per 1,000 kcal, with the
aim of expressing intake in terms of caloric density.
These components were weighted with values from 0 to
2, taking as a reference the population tertiles previously
published [21]. Adherence was rated as low (0–6), inter-
mediate (7–10) and high (11–18) [22].
Physical activity
To determine the level of physical activity, we used the
active leisure time concept developed by Bernstein et al.,
which defines a sedentary person as one who invests less
than 10 % of the daily energy expenditure in any kind of
physical activity which requires at least 4 METs (degree
of physical activity equal to or greater than the expend-
iture of walking at a fast pace for 30 min) [23].
Statistical analysis
A bivariate analysis between rMED and each of the
dimensions of the quality of life and treatment satisfac-
tion categories was performed by using Pearson and
Spearman correlation coefficients and, after recoding
rMED into categories to assess non-linear associations,
by using the Mann-Whitney U test (in case of only 2) or
Kruskal-Wallis test (for differences among the three
levels of rMED). For those dimensions with a significant
bivariate association with rMED, multivariate linear re-
gression models were adjusted by adding rMED to the
previously published model for global quality of life and
treatment satisfaction scores [15]. Non-significant vari-
ables in multivariate models were dropped from the final
model unless having shown a confounding effect or sig-
nificant interaction with another variable. The language
and environment for statistical computing known as R
was used as statistical software. A significance level of
0.05 was established.
Results
Table 1 shows the clinical and socio-demographic char-
acteristics and the relative Mediterranean Diet score of
the study population.
The bivariate analysis revealed that rMED was signifi-
cantly associated with the following HRQoL dimensions:
travels (p = 0.025 for differences among the three levels
of rMED), self-confidence (p = 0.006 for differences
among the two groups defined by rMED median), free-
dom to eat (p = 0.030 for differences among the two
groups defined by rMED median), and freedom to drink
(p = 0.005 for differences among the three levels of
rMED). Table 2 shows the results of a multivariate re-
gression model to explain the impact of adherence to
the MedDiet on the above mentioned items (“travels”,
“self-confidence”, “freedom to eat” and “freedom to
drink”). An intermediate-high rMED level was negatively
associated with the score in the item that assesses ease
of travel (p = 0.020).
On the contrary, a value in the rMED of 8 or above
was positively associated with the score in “self-confi-
dence” (p = 0.015), and the score in “freedom to eat”
(p = 0.037); a high rMED level was positively associ-
ated with “freedom to drink” (p = 0.015). The analysis
did not show any significant contribution of the
rMED to explain the variability in other quality-of-life
dimensions or in the final HRQoL score.
In the bivariate analysis, the rMED was associated with
the final treatment satisfaction score (p = 0.027 for dif-
ferences among the three levels of rMED) and with the
following treatment satisfaction dimensions: “hypergly-
caemias frequency perception” (p = 0.006 for trend
among the three levels of rMED), “understanding of
diabetes” (linearly correlated with rMED with r = 0.23,
p = 0.0001), and “treatment recommendation” (p = 0.047
for differences among the three levels of rMED). Table 3
shows the results of the multivariate regression model
to explain general treatment satisfaction after including
adherence to the MedDiet. The rMED score showed a
highly significant positive linear correlation with “un-
derstanding of diabetes” (p = 0.0004).
The “hyperglycemias frequency perception” was
positively associated with rMED values of 9 or above
(p = 0.039). The specific dimension “treatment recommen-
dation” (i.e., would recommend this form of treatment to
someone with a diabetes similar to yours) was associated
with high levels of rMED (p = 0.036). High levels of rMED
significantly contributed to explain higher values in overall
treatment satisfaction (p = 0.046). The analysis did not
demonstrate any other significant contribution between any
of the other dimensions of DTSQ and the rMED.
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Discussion
The current study indicates that a high adherence to the
MedDiet is associated with higher levels of overall treat-
ment satisfaction in patients with T2DM, and also with
some specific dimensions of this outcome variable
(perception of hyperglycaemias, understanding and rec-
ommend to others). Moreover, these results show that
an intermediate-high level of adherence to the MedDiet
is associated with some dimensions of an important
outcome variable for diabetic patients, i.e., HRQoL.
Despite the fact that recent observational studies dem-
onstrate the association that some components of the
MedDiet (antioxidants, fatty acid content and fibre intake)
have with the health status of the general population,
Table 2 Multivariate linear regression for dimensions from the
Audit of Diabetes Dependent Quality of Life
Coefficients rMED Estimate (SE) p-value
Travela >7 −0.450 (0.192) 0.020
Self-confidenceb >8 0.428 (0.175) 0.015
Freedom to eatc >8 0.839 (0.402) 0.037
Freedom to drinkd >8 1.150 (0.471) 0.015
aAdjusted for insulin treatment, retinopathy, diabetes duration and the
interaction diabetes duration*DR* insulin treatment. bAdjusted for
insulin treatment, retinopathy, diabetes duration, age (>65 years), waist and
the interaction diabetes duration*DR* insulin treatment. cAdjusted for insulin,
diabetes duration and ethnicity. dAdjusted for insulin treatment and ethnicity
DR diabetic retinopathy, rMED relative Mediterranean Diet score, SE standard
error
Table 3 Multivariate linear regression for dimensions from
Diabetes Treatment Satisfaction Questionnaires
Coefficients rMED Estimate (SE) p-value
Final scorea >11 2.107 (1.052) 0.046
Hyperglycemias frequency perceptionb ≥9 0.372 (0.179) 0.039
Understanding of diabetesc ≥9 0.163 (0.45) <0.001
Treatment recommendationd ≥11 0.823 (0.390) 0.036
aAdjusted for insulin treatment, retinopathy, diabetes duration, physical
activity (>20 min), smoking. and the interaction between diabetes
duration*DR. b,cAdjusted for physical activity (>20 min). dAdjusted for
retinopathy, diabetes duration and the interaction between diabetes
duration*DR
DR diabetic retinopathy, rMED relative Mediterranean Diet score, SE standard
error
Table 1 Clinical and demographic characteristics of the study groups
Characteristics No DR (n = 148) DR (n = 146) p-value
Age (years), mean (SD) 57.9 (10.3) 60.5 (8.8) 0.021
Sex, men, n (%) 77 (52 %) 73 (50 %) 0.816
Ethnicity, non caucasian, n (%) 5 (3.4 %) 6 (4.1 %) 0.769
HbA1c (%), mean (SD) 7.3 (1.2) 8.3 (1.4) <0.001
Diabetes duration (years), mean (SD) 7.1 (5.5) 14.1 (9.9) <0.001
Waist (cms), mean (SD) 104.2 (11.9) 107.8 (11.9) 0.010
Systolic blood pressure (mmHg), mean (SD) 134.3 (15.5) 145 (19.9) <0.001
Diastolic blood pressure (mmHg),mean (SD) 76.5 (10.5) 77.1 (11.1) 0.628
Total cholesterol (mg/dL), mean (SD) 185.7 (36.6) 184.8 (36.1) 0.822
HDL-cholesterol (mg/dL), mean (SD) 48.5 (10.7) 52.1 (15) 0.021
LDL-cholesterol (mg/dL), mean (SD) 111 (30.7) 106.9 (30.1) 0.182
Triglycerides (mg/dL), mean (SD) 138.6 (81.8) 140.5 (120) 0.879
Diabetes treatment <0.001
Oral agents 95 (64.2 %) 64 (43.8 %)
Insulin ± oral agents 17 (11.5 %) 79 (54.1 %)
Diet 36 (24.3 %) 3 (2.1 %)
Educational level, n (%) 0.629
≤ Primary 90 (60.8 %) 113 (77.4 %)
Secondary 40 (27.0 %) 30 (20.5 %)
Graduate or higher 18 (12.2 %) 3 (2.1 %)
Physical activity, n (%) 0.045
More than 25 min/day 98 (66.2 %) 81 (55.9 %)
Less than 25 min/day 50 (33.8 %) 64 (44.1 %)
rMED 8.3 (2.9) 7.7 (2.8) 0.220
DR diabetic retinopathy, HbA1c glycated haemoglobin, HDL high density lipoprotein, LDL low density lipoprotein, rMED relative Mediterranean Diet score, SD
standard deviation. Differences between groups were analyzed by Chi-squared or Fisher's exact text (qualitative variables) or Student's test (quantitative variables)
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there is an important knowledge gap in this area [2]. Only
a recent sub-analysis of the PREDIMED trial demon-
strated the role attributable to the Mediterranean diet
regime (enriched with nuts) in the prevention of unipolar
depression in patients with T2DM. A 40 % reduction was
observed in the risk of developing depression in patients
receiving Mediterranean diet in relation to the control
group [8]. In diabetic patients participating in that study,
the results did not achieve significance when this
approach was used with the MedDiet enriched with olive
oil. Although the current results suggest the potential im-
pact of adherence to the Mediterranean diet pattern on
quality of life of the diabetic patient, we could not find
epidemiological evidence on this association. We cannot
consider that the results of mental health status are com-
parable with those of quality of life, although we can inter-
pret that there is probably some interaction between
them. Also, despite the fact that the MedDiet, as an inte-
gral part of medical nutrition therapy of the patient with
T2DM, contributes to the control of metabolic parame-
ters, to the best of our knowledge this is the first study
showing a relationship of the adherence to the MedDiet
with an outcome variable as important in the field of
diabetes as overall treatment satisfaction.
This study has some limitations. First, its design as a
cross-sectional observational study did not allow us to
establish causal relations, but rather only relations of asso-
ciation. Second, the partial representativeness of the sam-
ple in relation to the overall population with diabetes
should be highlighted, given the exclusion of advanced late
complications in the selection of the patients from the
previous study. Finally, it should be stressed that the main
objective when the study was designed was not to analyze
the association between adherence to the MedDiet and
the results reported by the patient with T2DM. However,
the use of specific questionnaires designed to measure the
main outcome variables and of tools validated to assess
intake strengthens the results of the study.
Conclusion
The results of this study show that in patients with T2DM
high adherence to the MedDiet was associated with higher
diabetes treatment satisfaction. Moreover, despite the fact
that a significant association was not demonstrated with
the overall score of HRQoL, a higher adherence to the
MedDiet was associated with a better score in some of its
dimensions. There is a clear need to undertake new re-
search to analyze the causal relationships existing between
adherence to healthy eating patterns, on the one hand, and
quality of life and treatment satisfaction in the diabetic
patient on the other. It is important to define whether there
is a causal relationship or other associated factors in a bidir-
ectional manner between the food and nutrient intake
regime and the results reported by the patient with T2DM.
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